Study Showed That NICOM can be Used to Accurately Measure Cardiac Output
During Cardiopulmonary Exercise Testing (CPX)
WASHINGTON, September 19 /PRNewswire/ -- Cheetah Medical Inc., developers of the Cheetah NICOM(TM) system, for non-invasive, real-time cardiac output monitoring, announced at HFSA the results of the study "Markers of ventilatory inefficiency in heart failure are related to peak exercise."
The study, led by Dr. Jon Myers of Stanford University and the VA Palo Alto Health Care System, used the NICOM to measure the cardiac output of 36 patients. Results showed that the NICOM accurately measured cardiac output. This is the first time that the NICOM was used in a study during cardiopulmonary exercise on heart failure patients.
Dr. Myers concluded, "NICOM provided accurate measurements of cardiac output and thoracic fluid during cardiopulmonary exercise. The possibility of using a non-invasive, accurate tool to measure cardiac output may provide clinicians with an important diagnostic tool that can contribute to optimization of CHF treatment and provide an early indication of disease escalation."
The NICOM(TM) Cardiac Output Monitor, developed by Cheetah Medical, is a portable system that utilizes the proprietary BIOREACTANCE(TM) technology to measure cardiac output in virtually any clinical setting. Cheetah considers BIOREACTANCE to be a superior modality to measure cardiac output, especially in clinical settings where continuous monitoring of cardiac output is imperative, and in clinical environments such as intensive care units, emergency departments and during stress tests, where there is significant electrical noise and patient movement.
Cheetah's BIOREACTANCE(TM) technology has been validated in the United States and Europe on hundreds of hemodynamically challenged patients in a variety of clinical settings, in the presence of significant environmental factors.
Laura Rector, General Manager
|SOURCE Cheetah Medical Inc.|
Copyright©2007 PR Newswire.
All rights reserved